JOFABYO Trademark

Trademark Overview

On Wednesday, February 18, 2026, a trademark application was filed for JOFABYO with the United States Patent and Trademark Office. The USPTO has given the JOFABYO trademark a serial number of 99659652. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 18, 2026. This trademark is owned by IDORSIA PHARMACEUTICALS LTD. The JOFABYO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases; Pharmaceutical preparations for the treatment of hypertension, diabetes, and kidney diseases, including chronic kidney disease, diabetic kidney disease, and kidney diseases associated with glycolipid storage disorders and Fabry disease
jofabyo

General Information

Serial Number99659652
Word MarkJOFABYO
Filing DateWednesday, February 18, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, February 18, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases; Pharmaceutical preparations for the treatment of hypertension, diabetes, and kidney diseases, including chronic kidney disease, diabetic kidney disease, and kidney diseases associated with glycolipid storage disorders and Fabry disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 18, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIDORSIA PHARMACEUTICALS LTD
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAllschwil CH-4123
CH

Trademark Events

Event DateEvent Description
Wednesday, February 18, 2026NEW APPLICATION ENTERED
Wednesday, February 18, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 18, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

jofabyo diseases disease disorders kidney including fabry pharmaceutical storage glycolipid preparations